Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study

RW Elder, NM McCabe, C Hebson, E Veledar… - International journal of …, 2013 - Elsevier
Background Chronic congestive hepatopathy is known to cause hepatic fibrosis and portal
hypertension in patients post-Fontan operation for single ventricle palliation. The clinical …
被引用次数：165 相关文章

Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study.

RW Elder, NM McCabe, C Hebson… - … Journal of Cardiology, 2013 - europepmc.org
Background Chronic congestive hepatopathy is known to cause hepatic fibrosis and portal
hypertension in patients post-Fontan operation for single ventricle palliation. The clinical …
[HTML] nih.gov

[HTML][HTML] Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study

RW Elder, NM McCabe, C Hebson… - … journal of cardiology, 2013 - ncbi.nlm.nih.gov
Background Chronic congestive hepatopathy is known to cause hepatic fibrosis and portal
hypertension in patients post-Fontan operation for single ventricle palliation. The clinical …
[PDF] core.ac.uk

[PDF][PDF] Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study

RW Elder, NM McCabe, C Hebson, E Veledar… - core.ac.uk
Background—Chronic congestive hepatopathy is known to cause hepatic fibrosis and portal
hypertension in patients post-Fontan operation for single ventricle palliation. The clinical …

Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study

RW Elder, NM McCabe… - International …, 2013 - internationaljournalofcardiology.com
Background Chronic congestive hepatopathy is known to cause hepatic fibrosis and portal
hypertension in patients post-Fontan operation for single ventricle palliation. The clinical …
[PDF] fiu.edu

[PDF][PDF] Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study

RW Elder, NM McCabe, C Hebson, E Veledar… - 2013 - digitalcommons.fiu.edu
Background—Chronic congestive hepatopathy is known to cause hepatic fibrosis and portal
hypertension in patients post-Fontan operation for single ventricle palliation. The clinical …

[引用][C] Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study

RW ELDER, NM MCCABE… - International journal …, 2013 - pascal-francis.inist.fr
Features of portal hypertension are associated with major adverse events in Fontan patients:
The VAST study CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study

RW Elder, NM McCabe, C Hebson… - International …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Chronic congestive hepatopathy is known to cause hepatic fibrosis and portal
hypertension in patients post-Fontan operation for single ventricle palliation. The clinical …

[引用][C] Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study

RW Elder, NM McCabe, C Hebson, E Veledar… - International Journal of …, 2013 - cir.nii.ac.jp
Features of portal hypertension are associated with major adverse events in Fontan patients:
The VAST study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
[PDF] academia.edu

[PDF][PDF] Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study

RW Elder, NM McCabe - Int J Cardiol, 2013 - academia.edu
Background—Chronic congestive hepatopathy is known to cause hepatic fibrosis and portal
hypertension in patients post-Fontan operation for single ventricle palliation. The clinical …